Credit Suisse analyst Gretel Janu upgraded CSL to Outperform from Neutral with a A$310 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CSLLY:
- Biotech Alert: Searches spiking for these stocks today
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Arcturus Therapeutics upgraded to Equal Weight from Underweight at Barclays
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- CSL unit enters license agreement with Arcturus Therapeutics